Anzeige
Mehr »
Login
Mittwoch, 22.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
STRONG BUY! Kurs eskaliert - A Star is Born!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0E9TF | ISIN: FR0010193979 | Ticker-Symbol: 0B0
Frankfurt
21.01.25
08:02 Uhr
3,530 Euro
-0,130
-3,55 %
Branche
Immobilien
Aktienmarkt
Sonstige
1-Jahres-Chart
CBO TERRITORIA Chart 1 Jahr
5-Tage-Chart
CBO TERRITORIA 5-Tage-Chart
RealtimeGeldBriefZeit
3,5703,66021.01.
Actusnews Wire
501 Leser
Artikel bewerten:
(2)

CBo Territoria confirms its qualification for the French "PEA-PME" scheme (share savings plan designed to finance SMEs and ETIs)

Finanznachrichten News

Press release - Qualification for the French "PEA-PME" scheme

Sainte-Marie, June 24, 2024, 8 p.m.



CBo Territoria confirms its qualification for the French "PEA-PME" scheme (share savings plan designed to finance SMEs and ETIs)


CBo Territoria has announced that it meets all the qualifying criteria for share saving plans designed to finance SMEs and ETIs as specified in Article L. 221-32-2 of the French Monetary and Financial Code.

A company whose securities are admitted to trading on a regulated market must cumulatively meet the following conditions:

Qualifying criteria *CBo Territoria's consolidated figures
(to December 29, 2023)
Market capitalization of less than two billion euros€133.8M

* According to Article L. 221-32-2 of the French Monetary and Financial Code, a company is eligible for the PEA-PME scheme if its shares can be traded on a regulated market and its stock market capitalization is less than two billion euros, or was less than two billion euros at the end of at least one of the four calendar years preceding the fiscal year used to assess the eligibility of the issuing company's shares.


As a result, CBo Territoria's shares can be included in stock savings plans (also known as "PEA-PME") that are intended to finance SMEs and ETIs. These plans enjoy the same tax benefits as stock savings plans (also known as "PEA"), including a capital gains tax exemption, as long as no withdrawals are made for five years.

Find all the financial information of the CBo Territoria Group on our website www.cboterritoria.com.


2024 financial calendar

  • First half 2024 results: Wednesday, September 11, 2024 (after trading hours)


About CBo Territoria (FR0010193979, CBOT)

CBo Territoria has been a major real estate operator in La Réunion for nearly 20 years and has evolved into a multi-regional property developer specializing in tertiary assets (€318.9 million, representing 86% of total assets in value at 31 décembre 2023). The Group is pursuing its expansion through the exploitation of its land reserves or through land acquisition, as it is involved in the full real estate value chain (property developer, property investor, and real estate company). CBo Territoria can finance its development through its activities as a residential developer (apartment buildings or sale of land plots) and, secondarily, as a service provider, as well as through the planned transfer of its residual residential properties to SHLMR.

CBo Territoria is a real estate investment firm listed on Euronext Paris (compartment "C") that is qualified for the PEA PME finance program (small and medium-sized enterprises).

Responsible and committed to a more sustainable real estate since its inception, CBo Territoria has been in the Top 10 of compartment "C" of the Gai?a-Index for the past 6 years, a French benchmark index of the most virtuous small and medium-sized companies in terms of CSR (Corporate Social Responsibility).

More information on cboterritoria.com



INVESTORS Contacts

Caroline Clapier - Director of Finance and Administration - direction@cboterritoria.com

Agnès Villeret - Komodo - Tel.: 06 83 28 04 15 - agnes.villeret@agence-komodo.com

PRESS Contacts

Finance: Agnès Villeret - agnes.villeret@agence-komodo.com

Corporate - Paris: Dina Morin - dmorin@capvalue.fr

La Réunion & Mayotte: Catherine Galatoire - cgalatoire@cboterritoria.com

------------------------
This publication embed "Actusnews SECURITY MASTER".
- SECURITY MASTER Key: mJxylZdrY5mdyW2elZaaa2eUmGpqm5LIm5LLxmVslsiacGxmlm9kbZmZZnFnmWVs
- Check this key: https://www.security-master-key.com.
------------------------
Full and original release in PDF format:
https://www.actusnews.com/documents_communiques/ACTUS-0-86406-240624_20h_cbot_cp-pea-pme-vang.pdf

© Copyright Actusnews Wire
Receive by email the next press releases of the company by registering on www.actusnews.com, it's free
© 2024 Actusnews Wire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.